Download PDF
Dtsch Med Wochenschr 2017; 142(06): 418-426
DOI: 10.1055/s-0042-121336
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Differenzialtherapie von Kopfschmerzen

Headache Treatment
Hans Christoph Diener
,
Dagny Holle-Lee
,
Steffen Nägel
,
Charly Gaul
Further Information

Publication History

Publication Date:
22 March 2017 (online)

Also available at
    Permissions and Reprints

Abstract

A precondition for the successful treatment of headaches is the correct headache diagnosis. Triptans are effective for attack treatment of migraine and cluster headache. However, there are not effective for the treatment of tension-type headache. For the prevention of frequent episodic migraine betablockers, flunarizine, topiramate and amitriptyline are recommended. For the prevention of chronic migraine evidence is only available for onabotulinumtoxinA and topiramate. For prophylactic treatment of tension-type headaches tricyclic antidepressants are used. In cluster headache verapamil (in combination with steroids) is the most frequently used prophylactic agent. This article focusses on the current acute and prophylactic treatment of common headache syndromes.

Voraussetzung für eine erfolgreiche Kopfschmerztherapie ist die korrekte diagnostische Zuordnung. Die spezifischen Therapieansätze sind jedoch vielfältig und unterscheiden sich hinsichtlich einer Akut- oder Prophylaxebehandlung. Zusätzlich sind Komorbiditäten und Nebenwirkungen zu berücksichtigen, um einen individuell optimalen Behandlungserfolg bei Migräne, Kopfschmerz vom Spannungstyp oder trigeminoautonomen Kopfschmerzen zu erzielen.

Schlüsselwörter

Migräne - Kopfschmerz vom Spannungstyp - Trigeminoautonome Kopfschmerzen - Cluster Kopfschmerz

Key words

migraine - tension-type headache - trigeminal autonomic headaches - cluster headache
 

  • Literatur

  • 1 Cameron C. Kelly S. Hsieh SC. et al. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache 2015; 55: 221-235
    CrossrefPubMedGoogle Scholar
  • 2 Derry CJ. Derry S. Moore RA. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012; (02) DOI: 10.1002/14651858.CD009665.
    CrossrefPubMedGoogle Scholar
  • 3 Roberto G. Raschi E. Piccinni C. et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia 2015; 35: 118-131
    CrossrefPubMedGoogle Scholar
  • 4 Vikelis M. Mitsikostas DD. Rapoport AM. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Pain management 2014; 4: 123-128
    CrossrefPubMedGoogle Scholar
  • 5 Roberto G. Piccinni C. D'Alessandro R. et al. Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database. Cephalalgia 2014; 34: 5-13
    CrossrefPubMedGoogle Scholar
  • 6 Lipton RB. Fanning KM. Serrano D. et al. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 2015; 84: 688-695
    CrossrefPubMedGoogle Scholar
  • 7 Diener HC. Evers S. Fördereuther S. et al. Therapie der Migräne. In: Diener H. Weimar C. Berlit P. et al. Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme; 2012: 688-718
    Google Scholar
  • 8 Evers S. The efficacy of triptans in childhood and adolescence migraine. Curr Pain Headache Rep 2013; 17: 342
    CrossrefPubMedGoogle Scholar
  • 9 Ephross SA. Sinclair SM. Final results from the 16-year sumatriptan and treximet pregnancy registry. Headache 2014; 54: 1158-1172
    CrossrefPubMedGoogle Scholar
  • 10 Hutchinson S. Marmura MJ. Calhoun A. et al. Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache 2013; 53: 614-627
    CrossrefPubMedGoogle Scholar
  • 11 Cunnington M. Ephross S. Churchill P. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?. Headache 2009; 49: 1414-1422
    CrossrefPubMedGoogle Scholar
  • 12 Pinkerman B. Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia 2010; 30: 1187-1194
    CrossrefPubMedGoogle Scholar
  • 13 MacGregor EA. A review of frovatriptan for the treatment of menstrual migraine. Int J Womens Health 2014; 6: 523-535
    PubMedGoogle Scholar
  • 14 Janzen RWC. Gaul C. Migräneprophylaxe: Valproinsäure: Neues zum Off-Label-Use. Dtsch Arztebl 2015; 112 DOI: 10.3238/PersNeuro.2015.12.04.04.
    CrossrefPubMedGoogle Scholar
  • 15 Gaul C. Diener HC. Danesch U. et al. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 2015; 16: 516
    PubMedGoogle Scholar
  • 16 Diener H. Charles A. Goadsby P. et al. New therapeutic approaches for the prevention and treatment of migraine. Lancet neurology 2015; 14: 12
    PubMedGoogle Scholar
  • 17 Riederer F. Penning S. Schoenen J. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly Device for Migraine Prevention: A Review of the Available Data. Pain Ther 2015; DOI: 10.1007/s40122-015-0039-5.
    CrossrefPubMedGoogle Scholar
  • 18 Aurora SK. Winner P. Freeman MC. et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-Week PREEMPT clinical program. Headache 2011; 51: 1358-1373
    CrossrefPubMedGoogle Scholar
  • 19 Straube A. Gaul C. Förderreuther S. et al. Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society. Der Nervenarzt 2012; 83: 1600-1608
    CrossrefPubMedGoogle Scholar
  • 20 Kropp P. Meyer B. Dresler T. et al. Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 2016; 35: 502-515
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Straube A. Gaul C. Sandor P. et al. Therapie des episodischen und chronischen Kopfschmerzes vom Spannungstyp und anderer chronischer täglicher Kopfschmerzen. In: Diener H. Weimar C. Berlit P. et al. Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 5. Aufl. Stuttgart: Thieme; 2012: 719-730
    Google Scholar
  • 22 Robbins MS. Starling AJ. Pringsheim TM. et al. Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines. Headache 2016; 56: 1093-1106
    CrossrefPubMedGoogle Scholar
  • 23 May A. Evers S. Brössner G. et al. Leitlinie zur Diagnostik, Therapie und Prophylaxe von Cluster-Kopfschmerz, anderen trigemino-autonomen Kopfschmerzen, schlafgebundenem Kopfschmerz und idiopathisch stechenden Kopfschmerzen. Überarbeitete Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft in Zusammenarbeit mit der DGN, ÖKSG, SKG. Nervenheilkunde 2016; 35: 137-151
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Gaul C. Roguski J. Dresler T. et al. Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study. Cephalalgia 2016; DOI: 10.1177/0333102416654886.
    CrossrefPubMedGoogle Scholar